20157 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Wall or coating material Compounds of unknown constitution, e.g. material from plants or animals
Sub-classes:Surface-modified plant-derived extracellular vesicles and targeted drug delivery system using the same
#2Application, Extraction Method and Composition of Ganoderma lucidum Exosomes in Glioma Treatment
#3MILK DERIVED EXOSOMES AND USES THEREOF
#4METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES (IMMUNOCONTRACEPTION)
#5THERAPEUTIC AGENT-LOADED TISSUES FOR CORNEAL TRANSPLANT
#6NEW COATING SYSTEM (II)
#7EXTRACELLULAR VESICLES OR COMPOSITION THEREOF FOR USE AS A MEDICAMENT, SUCH AS FOR THE TREATMENT OF OCULAR SURFACE DISORDERS
#8COMPOSITIONS AND METHODS FOR IMPROVING NITROGEN UTILIZATION IN A RUMINANT
#9EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON ADMINISTRATION, AND USES
#10GENE EDITING TO TREAT MYELOPROLIFERATIVE NEOPLASMS
#11SOFT GEL COMPOSITIONS AND CAPSULES MADE FROM THE SAME
#12METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING A CARTILAGE DAMAGE USING SOX9 GENE
#13PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT
#14Aneurysm Treatment by Exosomes
#15EXOSOMES COMPRISING CORONAVIRUS-DERIVED ANTIGEN PROTEIN OR GENE ENCODING SAME PROTEIN, AND USE OF SAME
#16ENCAPSULATED BACTERIAL, METHODS AND USES THEREOF
#17COLON CANCER-SPECIFIC TARGET EXOSOME COMPOSITION AS DRUG DELIVERY MATERIAL, AND USE THEREOF
#18EXOSOME GENE THERAPY FOR TREATING INNER EAR DISEASE
#19COMPOSITIONS COMPRISING TOPIRAMATE FOR TREATING DERMATOLOGICAL CONDITIONS
#20LIQUID VISCOELASTIC SWALLOWING AID TO PROMOTE SAFE SWALLOWING OF SOLID ORAL DOSAGE FORMS (SODF)
#21COMPOSITIONS AND METHODS FOR IMPROVING BRAIN FUNCTION
#22METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES
#23Probiotic Microcapsule for the Treatment of Reproductive Tract Infection and Its Preparation Method and Application
#24ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE
#25LIQUID PHARMACEUTICAL COMPOSITIONS WITH STABLE DRUG RELEASE PROFILES
#26Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#27Soft gel compositions and capsules made from the same
#28NEW DELIVERY SYSTEM FOR POLYUNSATURATED FATTY ACIDS
#29DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#30Water-soluble lutein ester microcapsules and a method of preparing the same
#31LIPID COMPOSITION FOR ENCAPSULATING AN ACTIVE SUBSTANCE, PERMITTING CONTROL OF THE RATE OF RELEASE OF SAID ACTIVE SUBSTANCE
#32PRENATAL PROBIOTIC FORMULATIONS
#33SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS FOR TOPICAL INTESTINAL DELIVERY OF VITAMIN B3
#34TASTE MASKING DRUG FORMULATIONS
#35Process for the production of compressed tablets
#36MOISTURE RESISTANT PROBIOTIC GRANULE AND METHODS OF PRODUCING THE SAME
#37Formulation
#38Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#39Probiotic microcapsule
#40PROTECTING A BIOACTIVE AND/OR PRECURSOR THEREOF
#41Method for the production of microgel building blocks from pollen
#42Enterically coated cysteamine, cystamine and derivatives thereof
#43Compositions and methods for improving nitrogen utilization in a ruminant
#44Oral dosage form
#45DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#46Taste masking drug formulations
#47Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#48Modified resveratrol composition and use thereof
#49System and method for industrial encapsulation of thermolabile substances
#50Soft gel compositions and capsules made from the same
#51TIME RELEASE OF FAT-SOLUBLE ACTIVES
#52Formation of a janus microcapsule
#53Enterically coated cysteamine, cystamine and derivatives thereof
#54Use of decellularized extracellular matrix for encapsulating cells
#55Compositions and methods for stabilization of active agents
#56Enzyme delivery systems and methods of preparation and use
#57Method for preparing granules or pills containing extracts in high concentration
#58BEADLETS COMPRISING CAROTENOIDS
#59Process for the production of compressed tablets
#60Therapeutic nanoparticles and methods of use thereof
#61PROBIOTIC FORMULATIONS
#62Injectable microtissue systems, devices, and methods
#63Curcumin solid lipid particles and methods for their preparation and use
#64Microcapsules comprising lutein or lutein ester
#65Enterically coated cysteamine, cystamine and derivatives thereof
#66Enterically coated cysteamine, cystamine and derivatives thereof
#67Enterically coated cysteamine, cystamine and derivatives thereof
#68Compositions and methods for selective GI tract delivery
#69COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#70Method for introducing exogenous substance into cell, and material used in said method
#71DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#72Enterically coated cysteamine, cystamine and derivatives thereof
#73Taste masking drug formulations
#74Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders
#75Enterically coated cysteamine, cystamine and derivatives thereof
#76Enterically coated cysteamine, cystamine and derivatives thereof
#77NORTHERN WHITE KIDNEY BEAN EXTRACT AND CERATONIA SILIQUA EXTRACT IN COMBINATION WITH GREEN TEA EXTRACT IN THE TREATMENT OF EXCESS WEIGHT AND OBESITY
#78Enzyme delivery systems and methods of preparation and use
#79Edible plant-derived microvesicle compositions including conjugated therapeutic agents and methods for using the same
#80Enzyme delivery systems and methods of preparation and use
#81Method for silk fibroin gelation using sonication
#82Use of decellularized extracellular matrix for encapsulating cells
#83Enzyme delivery systems and methods of preparation and use
#84Method for preparing granules or pills containing extracts in high concentration
#85Pharmaceutical preparation and method for treatment of diabetes
#86Therapeutic nanoparticles and methods of use thereof
#87Methods for production and use of substance-loaded erythrocytes (S-IEs) for observation and treatment of microvascular hemodynamics
#88Shellac-coated particles of active ingredients with controlled release properties at high pH-values, process for their manufacture and use thereof
#89Novel Preparation Of An Enteric Release System
#90Therapeutic nanoparticles and methods of use thereof
#91Solventless mixing process for coating pharmaceutical ingredients
#92DRUG CARRIER AND PREPARATION METHOD THEREOF
#93Polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
#94Microvesicles derived from cell protoplast and use thereof
#95Method for silk fibroin gelation using sonication
#96Silk-based ionomeric compositions
#97COMPLEX FORMULATION COMPRISING ASPIRIN COATED WITH BARRIER CONTAINING HYDROPHOBIC ADDITIVE, AND HMG-COA REDUCTASE INHIBITOR
#98Preparation of an enteric release system
#99ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
#100Enzyme Delivery Systems and Methods of Preparation and Use
#101Enzyme delivery systems and methods of preparation and use
#102Enterically coated cysteamine, cystamine and derivatives thereof
#103Methods for preparing pharmaceuticals by emulsion aggregation processes
#104METHODS FOR PRODUCTION AND USE OF SUBSTANCE-LOADED ERYTHROCYTES (S-IEs) FOR OBSERVATION AND TREATMENT OF MICROVASCULAR HEMODYNAMICS
#105ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS
#106Encapsulation of oxidatively unstable compounds
#107FORMULATIONS COMPRISING EXINE SHELLS
#108DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#109Novel Preparation of an Enteric Release System
#110Enzyme delivery systems and methods of preparation and use
#111Method for silk fibroin gelation using sonication
#112PROTEIN-CONTAINING SUBSTANCE WITH INCREASED THERMAL STABILITY
#113Microsphere beeswax for mammalian dietary fat mitigation
#114Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
#115Enterically coated cystamine, cysteamine and derivatives thereof
#116Stable non-disintegrating dosage forms and method of making same
#117Enteric-Coated Glucosinolates And Beta-Thioglucosidases
#118COATING FOR OXYGEN SENSITIVE MATERIALS
#119Coated material and process for producing the coated material
#120Transdermal delivery patch
#121Multi-layered coating technology for taste masking
#122Pharmaceutical compositions comprising aloe pectins, and methods for their production and use
#123Washing apparatus
#124Compositions and methods for timed release of a water-soluble nutritional supplement, methylsulfonylmethane
#125Compositions and methods for timed release of water-soluble nutritional supplements